Asset Management One Co. Ltd. raised its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 9.4% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 259,461 shares of the financial services provider’s stock after purchasing an additional 22,278 shares during the quarter. Asset Management One Co. Ltd.’s holdings in MetLife were worth $21,400,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. Norden Group LLC raised its position in MetLife by 152.9% in the 1st quarter. Norden Group LLC now owns 8,115 shares of the financial services provider’s stock worth $601,000 after buying an additional 4,906 shares during the last quarter. GSA Capital Partners LLP bought a new position in MetLife during the first quarter valued at approximately $653,000. Rehmann Capital Advisory Group grew its position in MetLife by 3.5% in the 1st quarter. Rehmann Capital Advisory Group now owns 7,423 shares of the financial services provider’s stock worth $550,000 after purchasing an additional 251 shares during the period. Mediolanum International Funds Ltd purchased a new stake in MetLife during the 1st quarter valued at $4,637,000. Finally, Avidian Wealth Solutions LLC lifted its holdings in shares of MetLife by 4.2% during the 1st quarter. Avidian Wealth Solutions LLC now owns 4,505 shares of the financial services provider’s stock valued at $334,000 after buying an additional 182 shares during the period. 89.81% of the stock is owned by hedge funds and other institutional investors.
MetLife Trading Up 0.2 %
MET stock opened at $78.15 on Wednesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1-year low of $58.89 and a 1-year high of $86.94. The business has a 50 day simple moving average of $80.73 and a two-hundred day simple moving average of $75.03. The company has a market capitalization of $54.73 billion, a price-to-earnings ratio of 15.76, a PEG ratio of 0.71 and a beta of 1.05.
MetLife Announces Dividend
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the company. TD Cowen initiated coverage on MetLife in a research report on Wednesday, October 9th. They issued a “buy” rating and a $97.00 target price on the stock. Morgan Stanley dropped their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Bank of America reduced their target price on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a report on Thursday, August 1st. Jefferies Financial Group boosted their price objective on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Finally, Barclays decreased their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $88.46.
Get Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Palantir Cracks $50, Is There Still Time to Get on Board?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Insider Buying Signals Upside for These 3 Stocks
- How to buy stock: A step-by-step guide for beginners
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.